Skip to main content
. 2017 Nov 1;6(5):76–83.

Table 5.

Secondary efficacy endpoint-Infection associated parameters

All N=62
Infections
    Number of infections (nb of patients) 228 (51)
    Median annualised number of infections/patient (nb/year) [min-max] 3.0 [0.0-14.9]
    [95% IC] [2.88; 4.71]
Infections with antibiotic use
    Number of infections (nb of patients) 131 (38)
    Median annualized nb of days of antibiotics (days/year) [min-max] 7.5 [0.0-120.8]
    [95% IC] [12.7; 26.3]
Hospitalizations due to infection
    Number of hospitalizations (nb of patients) 6 (5)
    Median annualized nb of days/patient [min-max] 0.0 [0.0-17.7]
    [95% IC] [0.05; 1.73]
Absence from work or school due to infections
    Number of absence (nb of concerned patients) 15 (8)
    Median annualized nb of days of absence/patient (days/year) [min-maxi] 0.0 [0.0-20.0]
    [95% IC] [0.09; 1.93]

nb: number.